Author | Sanjiv S. Agarwala, MD | OncLive

Author | Sanjiv S. Agarwala, MD

Articles

Dr. Agarwala on Impact of Combining Entinostat with Pembrolizumab

July 20, 2018

Sanjiv S. Agarwala, MD, chief of medical oncology and hematology, St. Luke’s Cancer Center, professor of medicine, Temple University School of Medicine, discusses the impact of combining entinostat with pembrolizumab (Keytruda) across a number of tumor types.

Dr. Agarwala on the Significance of OS and Toxicity Results in CheckMate-067

May 09, 2017

Sanjiv S. Agarwala, MD, chief of medical oncology and hematology, St. Luke’s Cancer Center, professor of Medicine, Temple University School of Medicine, discusses whether the overall survival (OS) justifies the toxicities demonstrated in the CheckMate-067 trial for patients with melanoma.

x